Author
Paul J. Hergenrother
Recent research
- Health & MedicineOpen access
Triple negative breast cancer (TNBC) is a highly aggressive breast cancer that is unresponsive to hormonal therapies. One potential TNBC-specific therapeutic target is NQO1, as it is highly expressed in many TNBC patients and lowly expressed in non-cancer tissues. Here we use a d...
- Health & Medicine
Small-Molecule Inhibitors of Cholesterol Sulfotransferase as Immunomodulatory Agents
Though immune checkpoint blockade (ICB) therapy has been a promising advance in cancer treatment, response rates to ICB are low owing to other mechanisms that cancers employ to evade the immune system. SULT2B1b is an enzyme known to produce cholesterol sulfate (CS), an immunosupp...